rs1043801 - COL6A2
Magnitude 2.2 · 1 study on file
Reported associations
-
Translational genomics of osteoarthritis in 1,962,069 individuals - Unknown journal (n.d.) · Unknown authors · PubMed 40205036
ABSTRACT: Osteoarthritis is the third most rapidly growing health condition associated with disability, after dementia and diabetes. By 2050, the total number of patients with osteoarthritis is estimated to reach 1 billion worldwide. As no disease-modifying treatments exist for osteoarthritis, a better understanding of disease aetiopathology is urgently needed. Here we perform a genome-wide association study meta-analyses across up to 489,975 cases and 1,472,094 controls, establishing 962 independent associations, 513 of which have not been previously reported. Using single-cell multiomics data, we identify signal enrichment in embryonic skeletal development pathways. We integrate orthogonal lines of evidence, including transcriptome, proteome and epigenome profiles of primary joint tiss
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Discuss with your doctor
-
Knee health prevention strategies Moderate
COL6A2 genetic risk for OA warrants personalized discussion of timing and intensity of preventive measures
Exercise
-
Joint-protective exercise Moderate
Strength training reduces joint stress and cartilage wear; COL6A2 variant indicates particular importance for knee stability
Strength training 2-3x/week focusing on quadriceps, hamstrings, glute stabilizers; low-impact cardio 150min/week
Lifestyle
-
Weight management Moderate
Excess weight increases load on knee joints; particularly important for COL6A2 risk carriers
BMI 18.5-24.9; if overweight, aim for 5-10% weight loss
Screening
-
Knee joint monitoring Moderate
COL6A2 risk allele strongly associated with knee osteoarthritis; earlier detection enables preventive intervention
Baseline knee assessment by age 40; repeat every 2-3 years or if symptoms develop